SGMO – sangamo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results [Yahoo! Finance]
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Sangamo Therapeutics (SGMO) Reports Q1 Loss, Lags Revenue Estimates [Yahoo! Finance]
Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results [Yahoo! Finance]
Form 10-Q SANGAMO THERAPEUTICS, For: Mar 31
Form 8-K SANGAMO THERAPEUTICS, For: May 09
Form 8-K SANGAMO THERAPEUTICS, For: Apr 24
Form ARS SANGAMO THERAPEUTICS, For: Dec 31
Form DEF 14A SANGAMO THERAPEUTICS, For: Jun 04
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.